Yingqiang Liu, Zhengsheng Zhan, Zhuang Kang, Mengyuan Li, Yongcong Lv, Shenglan Li, . . . Jian Ding. (2023). Preclinical and early clinical studies of a novel compound SYHA1813 that efficiently crosses the blood-brain barrier and exhibits potent activity against glioblastoma. Elsevier.
Chicago Style (17th ed.) CitationYingqiang Liu, et al. Preclinical and Early Clinical Studies of a Novel Compound SYHA1813 That Efficiently Crosses the Blood-brain Barrier and Exhibits Potent Activity Against Glioblastoma. Elsevier, 2023.
MLA (9th ed.) CitationYingqiang Liu, et al. Preclinical and Early Clinical Studies of a Novel Compound SYHA1813 That Efficiently Crosses the Blood-brain Barrier and Exhibits Potent Activity Against Glioblastoma. Elsevier, 2023.
Warning: These citations may not always be 100% accurate.